A Study to Determine the Fasting Bioequivalence of Reformulated OXY Tablets and Original OxyContin® (OXY) Tablets
Clinical trial NCT01101191 · COMPLETED
Trial details
- NCT number
- NCT01101191
- Sponsor
- Purdue Pharma LP
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Primary completion
- 2007-10-01
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.